Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,220 | -26,431 | -22,022 | -17,525 | -5,188 |
| Depreciation Amortization | 13 | 52 | 39 | 26 | 13 |
| Other Working Capital | -244 | 37 | -586 | -210 | 487 |
| Other Operating Activity | 1,124 | 9,389 | 9,248 | 9,053 | 865 |
| Operating Cash Flow | $-4,327 | $-16,953 | $-13,321 | $-8,656 | $-3,823 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 132 | 132 | 132 | N/A |
| Common Stock Issued | 28,938 | 16,522 | 5,182 | 29 | N/A |
| Other Financing Activity | -5,749 | -329 | -218 | -144 | -73 |
| Financing Cash Flow | $23,189 | $16,325 | $5,097 | $17 | $-73 |
| Beginning Cash Position | 17,640 | 18,268 | 18,268 | 18,268 | 18,268 |
| End Cash Position | 36,501 | 17,640 | 10,044 | 9,629 | 14,372 |
| Net Cash Flow | $18,861 | $-628 | $-8,224 | $-8,639 | $-3,896 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,327 | -16,953 | -13,321 | -8,656 | -3,823 |
| Free Cash Flow | -4,327 | -16,953 | -13,321 | -8,656 | -3,823 |